REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
18/05/2026
Voltar para busca
Dado oficial do USPTO
TANNQUILYNNE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
19/05/2026
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
24/10/2018
Data de registro
18/05/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/05/2021
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
New Taipei City, TW
Examinador
VAGHANI, MAYUR C
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SyneuRx International (Taiwan) Corp.
Representantes
Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Syrups for pharmaceutical purposes for the treatment of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes; Pharmaceutical preparations for the treatment of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes; Pharmaceutical preparations for the treatment and prevention of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Transdermal patches for use in the treatment of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes; Natural dietary supplements for the treatment of Hyperglycemiadiabetesprediabetesinsulin resistancediabetic ketoacidosis (DKA)hyperglycemic hyperosmolar nonketotic syndrome (HHNS)HyperthyroidismPolyphagiapolydipsiapolyuriaglycosuriaincreased thirst and a frequent need to Urinatecomaabdominal painpoor wound healingStomach and intestinal problems such as chronic constipation or diarrheaWorse visionDamage to eyesblood vesselskidneyshyperlipidemiahypertriglyceridemiahypercholesterolemiaobesityhypertensionheart diseaseheart attackstrokethrombosisfatty liverliver cirrhosishyperuricemiagoutpain in jointsjoint stiffnessredness and swellingAutismAsperger's disorderpanic disorderpost-traumatic stress disorderpainchildhood learning disorderattention deficit hyperactivity disorder (ADHD)Tourette's syndromemaniaobsessive compulsive disorderother diseases or symptoms related to CNS disordermetabolic disorderdiabetes
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
18/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2021
PUBO
PUBLISHED FOR OPPOSITION
02/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2021
OTHE
CASE RETURNED TO EXAMINATION
31/12/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
31/12/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/10/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
28/10/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
28/10/2020
EX3G
SOU EXTENSION 3 GRANTED
28/10/2020
APET
ASSIGNED TO PETITION STAFF
18/10/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
18/09/2020
EXT3
SOU EXTENSION 3 FILED
10/09/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/09/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
10/09/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/07/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
24/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/07/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/02/2020
EX2G
SOU EXTENSION 2 GRANTED
27/02/2020
EXT2
SOU EXTENSION 2 FILED
27/02/2020
EEXT
SOU TEAS EXTENSION RECEIVED
27/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/08/2019
EX1G
SOU EXTENSION 1 GRANTED
13/08/2019
EXT1
SOU EXTENSION 1 FILED
13/08/2019
EEXT
SOU TEAS EXTENSION RECEIVED
13/08/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/03/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/01/2019
PUBO
PUBLISHED FOR OPPOSITION
15/01/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/12/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2018
DOCK
ASSIGNED TO EXAMINER
07/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/11/2018
NWAP
NEW APPLICATION ENTERED
27/10/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TANNQUILYNNE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.